AstraZeneca

  • Bevespi 2017 report

    Bevespi 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Brilinta 2017 report

    Brilinta 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Bydureon 2017 report

    Bydureon 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Calquence 2017 report

    Calquence 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Farxiga 2017 report

    Farxiga 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Faslodex 2017 report

    Faslodex 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 27 Pages The 5 Key Questions Addressed by this Report:...

  • Imfinzi 2017 report

    Imfinzi 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Iressa 2017 report

    Iressa 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Lynparza 2017 report

    Lynparza 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Movantik 2017 report

    Movantik 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Onglyza 2017 report

    Onglyza 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Symbicort 2017 report

    Symbicort 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this Report:...